PL2444081T3 - Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol - Google Patents

Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol

Info

Publication number
PL2444081T3
PL2444081T3 PL11008419T PL11008419T PL2444081T3 PL 2444081 T3 PL2444081 T3 PL 2444081T3 PL 11008419 T PL11008419 T PL 11008419T PL 11008419 T PL11008419 T PL 11008419T PL 2444081 T3 PL2444081 T3 PL 2444081T3
Authority
PL
Poland
Prior art keywords
cannabidiol
treatment
composition
inflammatory diseases
boswellic acids
Prior art date
Application number
PL11008419T
Other languages
English (en)
Inventor
Jirí Skalicky
Jirí Husek
Jana Hofbauerová
Milan Dittrich
Original Assignee
Parenteral A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20100764A external-priority patent/CZ2010764A3/cs
Priority claimed from CZ20110541A external-priority patent/CZ2011541A3/cs
Application filed by Parenteral A S filed Critical Parenteral A S
Publication of PL2444081T3 publication Critical patent/PL2444081T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL11008419T 2010-10-19 2011-10-19 Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol PL2444081T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20100764A CZ2010764A3 (cs) 2010-10-19 2010-10-19 Kompozice pro lécbu zánetlivých onemocnení
CZ20110541A CZ2011541A3 (cs) 2011-08-30 2011-08-30 Kompozice pro lécbu zánetlivých onemocnení
EP11008419.1A EP2444081B1 (en) 2010-10-19 2011-10-19 A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol

Publications (1)

Publication Number Publication Date
PL2444081T3 true PL2444081T3 (pl) 2015-09-30

Family

ID=45033650

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11008419T PL2444081T3 (pl) 2010-10-19 2011-10-19 Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol

Country Status (4)

Country Link
EP (1) EP2444081B1 (pl)
ES (1) ES2541485T3 (pl)
HU (1) HUE026929T2 (pl)
PL (1) PL2444081T3 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3232808B1 (de) * 2014-12-19 2020-04-01 THC Pharm GmbH The Health Concept Cbd-haltiges getränk
AU2016226267A1 (en) * 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
CA2991530C (en) 2015-07-06 2023-12-12 Cg-Bio Genomics, Inc. Supplement compositions comprising oils, cannabis and herbal extracts, and uses thereof
GB2542797A (en) 2015-09-29 2017-04-05 Gw Pharma Ltd Use of cannabinoids in the treatment of inflammatory skin diseases
LT6485B (lt) 2016-04-04 2018-01-10 UAB "SatiMed" Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui
JP2019523282A (ja) * 2016-08-03 2019-08-22 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド ***組成物
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
AU2018221881B2 (en) * 2017-02-15 2023-09-14 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of acne
AU2018221882A1 (en) * 2017-02-15 2019-09-05 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of psoriasis
AU2018221880B2 (en) * 2017-02-15 2023-08-17 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
WO2019109131A1 (en) * 2017-12-04 2019-06-13 Botanix Pharmaceuticals Ltd Antibacterial treatment using cannabinoids
EP3743054A4 (en) * 2018-01-24 2021-11-10 Botanix Pharmaceuticals Ltd CANNABINOID DOSAGE REGIME FOR DERMATITIS AND INFLAMMATORY SKIN DISORDERS
CA3089346A1 (en) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for acne
US20210052492A1 (en) * 2018-01-24 2021-02-25 Botanix Pharmaceuticals Ltd. Cannabinoid Dosing Regime For Psoriasis
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
US20190240148A1 (en) * 2018-02-07 2019-08-08 Tarukino Holdings, Inc. Lubricant composition and method for preparing the composition
KR102041876B1 (ko) * 2018-02-14 2019-11-08 (주)카이언바이오텍 칸나비디올 또는 그 유도체를 함유하는 아토피 개선용 화장료 조성물
IT201800005002A1 (it) * 2018-05-02 2019-11-02 Composizioni comprendenti estratti di boswellia e butirrati
JP2021532171A (ja) * 2018-07-02 2021-11-25 コンパニオン サイエンシズ リミテッド ライアビリティ カンパニー カンナビジオールの組み合わせ組成物
US10668045B2 (en) * 2018-07-12 2020-06-02 Bright Green Corporation Topical massage oil and cream containing CBD, CBN, curcumin and Boswellia resin
WO2020044123A1 (en) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Therapeutic combinations of boswellia extract and cannabinoids
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
JP2022509008A (ja) * 2018-11-12 2022-01-20 漢義生物科技（北京）有限公司 カンナビノイド化合物の神経皮膚炎の治療における応用
IT201900003325A1 (it) * 2019-03-07 2020-09-07 C I A M S R L Composizione per la prevenzione e trattamento della dermatite atopica
US20220233465A1 (en) * 2019-05-22 2022-07-28 Canopy Growth Corporation Cannabinoid-comprising compositions for management of pain
CN110269839A (zh) * 2019-06-15 2019-09-24 云南飞久逍科技有限公司 一种***二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用
IT201900016709A1 (it) * 2019-09-19 2021-03-19 Aqma Italia S P A Composizione antidolorifica e antinfiammatoria ad uso locale
WO2021072419A1 (en) * 2019-10-07 2021-04-15 Colgate-Palmolive Company Personal care compositions and methods
IT202000024217A1 (it) 2020-10-14 2022-04-14 Sanitas Laboratorio Chimico Farm S R L Composizione farmaceutica ad effetto analgesico a base di acmella olearacea ed altri principi attivi
CN113521004B (zh) * 2021-06-24 2022-02-22 中国农业科学院农产品加工研究所 一种高负载***二酚水包油大分子颗粒乳液的制备方法
BE1028576B1 (fr) * 2021-12-30 2023-08-17 Dyna S A R L Composition comprenant au moins un acide boswellique et/ou au moins un extrait végétal comprenant au moins un acide boswellique pour utilisation topique dans le traitement des maladies inflammatoires de la peau

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
WO2008127459A1 (en) * 2007-04-16 2008-10-23 Blum Richard S Pharmacological treatment of psoriasis
WO2009157016A2 (en) * 2008-06-03 2009-12-30 Ganga Raju Gokaraju Anti-adipocyte fatty acid-binding protein (ap2), anti flap and anti-cysltl1 receptor herbal compositions
WO2010127033A1 (en) * 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same

Also Published As

Publication number Publication date
EP2444081A1 (en) 2012-04-25
EP2444081B1 (en) 2015-04-08
ES2541485T3 (es) 2015-07-21
HUE026929T2 (en) 2016-08-29

Similar Documents

Publication Publication Date Title
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
EP2621499A4 (en) METHODS OF TREATING ALLERGIC DISEASES
EP2600857A4 (en) TREATMENT OF OCHONDRIAL DISEASES WITH NAPHTHOCHINONES
ZA201303057B (en) Ibat inhibitor for the treatment of liver diseases
PL2646425T3 (pl) Kwasy indanyloksydihydrobenzofuranylooctowe użyteczne do leczenia zespołu metabolicznego
ZA201208535B (en) Formulations of quinones for the treatment of ophthalmic diseases
ZA201301601B (en) Treatment of diseases
GB2503066B8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
HRP20150117T1 (en) Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
EP2613786A4 (en) TREATMENT OF DISEASES
EP2564845A4 (en) MEDICINE FOR TREATING HYPERPLASIC AND INFLAMMATORY DISORDERS IN HUMANS BASED ON DIINDOLYLMETHANE
HK1171677A1 (en) Composition for the treatment of hemorrhoids and related diseases
GB2496688B (en) Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
GB201302656D0 (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
EP2575824A4 (en) METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
GB201202095D0 (en) Topical medicament for the treatment of psoriasis
IL218001A0 (en) Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
EP2480099A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES
EP2600864A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
EP2767286A4 (de) Orale pharmazeutische zusammensetzung zur behandlung von entzündlichen magen-darm-erkrankungen
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds